Roy de Souza | |
|---|---|
| Born | 1970 (age 54–55) Nairobi, Kenya |
| Education | University of Oxford (M.S. in Engineering) Kellogg Business School (M.B.A.) |
| Occupations |
|
| Known for | Cancer research (AI Drug Discovery Per Patient) |
| Spouse | |
| Children | 3 |
| Father | Fitz de Souza |
| Relatives |
|
Roy de Souza (born 1970) is a Kenyan-born tech entrepreneur and writer. He is the co-founder of technology company ZEDO and medical technology company BreakBio. [1] [2] In 2022, he was a TEDx speaker. [3] In May of 2023 he and his late wife were honored by the American Cancer Society for Roy's work in personalized medicine. [4]
He earned a master's degree in engineering from the University of Oxford and an MBA from Kellogg Business School. [1]
De Souza served as a strategy consultant at the COBA Group, a strategy consulting boutique based in the UK. [5] [6] He also worked in product management for the Elon Musk-founded web software company Zip2. [7]
De Souza founded technology company ZEDO in 1999. [1] [8] In 2006, he founded the company Zebo, an offshoot of ZEDO focused on allowing users to catalog personal possessions and shop for similar items. [9] [10] [11] De Souza launched online ad exchange ZINC India in 2011, which was originally ZEDO's ad exchange platform in India before becoming a separate company. [12] [13] [14] He served as the ZEDO's CEO and oversaw the company as it transitioned into a subsidiary of Discovery following its acquisition by Discovery, Inc. in 2021. [15] [16] [17]
In 2022, he was a TEDx speaker, talking about vaccines to prevent cancer. . [3]
After his wife, Aisha de Sequeira's cancer diagnosis, de Souza became involved in vaccine research to develop a personalized vaccine for her cancer. [1] De Souza went on to co-found medical technology company BreakBio, basing the company in Boston, Massachusetts. [1] [2] [18] BreakBio develops personalized vaccines [2] and AI software that aids cancer treatments by identifying that difference between normal cells and cancer cells. [19] De Souza and Devabhaktuni Srikrishna also co-authored the book Cancer: What a Personal Crisis Taught Us About How T-Cells Can Save Your Life. [20]